Komodo Health and Janssen Research & Development have signed an agreement to use real-world data and artificial intelligence (AI) software for accelerating clinical development.

As part of the collaboration, feasibility, site selection, and patient recruitment will be optimised for clinical trials.

This is expected to drive higher throughput for trials and fast track life-saving therapies to patients.

Komodo Health chief medical officer Aswin Chandrakantan said: “The next generation of clinical trials requires deep and timely insight into the patient journey.

“Whether targeting a large volume of diverse patients for a prevalent chronic condition or exploring breakthroughs for complex rare diseases, it’s crucial to understand where patients are progressing through the care system in order to improve efficiency in clinical trials.”

At present, the partnership focuses on software solutions that offer real-time visibility into patient volumes.

How well do you really know your competitors?

Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.

Company Profile – free sample

Thank you!

Your download email will arrive shortly

Not ready to buy yet? Download a free sample

We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form

By GlobalData
Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.

This improves the ability to identify trial sites, increase target recruitment. Furthermore, patient cohorts could be understood prior to launch, and reach diverse patient populations.

The collaboration will cover therapeutic areas ranging from common chronic illnesses to ultra-rare diseases and its areas include infectious diseases, oncology, vaccines, immunology, cardiovascular, and metabolic disease.

The Komodo Health solutions are built on its Healthcare Map of 325 million US de-identified patient journeys.

Solutions that are being deployed include ‘Prism’ to support patient cohort analytics, ‘Sentinel’ for data integration, analytics, and site selection, and ‘Pulse’ for real-time alerts on encounters between providers and potential screening eligible patients.

Komodo Health applies AI and other advanced data science techniques to its Healthcare Map.